MOLN:NASDAQ
Molecular Partners AG
$4.21
arrow_upward
+7.40%(+0.29) 1D
Set 18, 4:00:00 PM GMT-4 · USD
search
Lahat ng simbolo
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa MOLN...
Buksan
$4.02
Mataas
$4.72
Mababa
$4.02
Mkt. cap
169.47M
Avg. na dami
1.16K
Dami
2.86K
Mataas nang 52-wk
$5.36
Mababa nang 52-wk
$3.53
EPS
-$1.66
Beta
1.02
Mga natitirang share
40.38M
Bilang ng mga empleyado
134
Buksan
$4.02
Mataas
$4.72
Mababa
$4.02
Mkt. cap
169.47M
Avg. na dami
1.16K
Dami
2.86K
Mataas nang 52-wk
$5.36
Mababa nang 52-wk
$3.53
EPS
-$1.66
Beta
1.02
Mga natitirang share
40.38M
Bilang ng mga empleyado
134
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
CarePlus VietNam
·
4 linggo ang nakalipas
Molecular (MOLN) Latest Quarter: EPS Beats Its Estimate in the Latest Reading; Price Move: Shares Move 4.02% Higher in the Latest Reading - Surprise Factor Analysis
CarePlus VietNam
·
1 buwan ang nakalipas
MOLN Q4 2025 Earnings: Loss Narrower Than Expected Amid Continuing Development Focus - One-Time Loss Impact
CarePlus VietNam
·
2 buwan ang nakalipas
MOLN Q4 2025 Earnings: EPS Beat Highlights Cost Discipline, Stock Slips 4.9% - Book Value Growth
Profile
Molecular Partners AG is a clinical-stage biopharmaceutical company based in Zürich, Switzerland. The company is developing a new class of potent, specific and versatile small-protein therapies called DARPins, with potential clinical applications in a range of disease areas including oncology, immuno-oncology, ophthalmology, and infectious diseases. Molecular Partners currently has two DARPin molecules in clinical development, and a broad pipeline of molecules in preclinical development. Wikipedia
Tungkol sa Molecular Partners AG